Literature DB >> 12849479

Multiple sclerosis exacerbations and infection.

Donald H Gilden1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12849479     DOI： 10.1016/s1474-4422(02)00066-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

2.  Virus-mediated autoimmunity in Multiple Sclerosis.

Authors:  Nikolaos Grigoriadis; Georgios M Hadjigeorgiou
Journal:  J Autoimmune Dis       Date:  2006-02-19

3.  COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.

Authors:  Mohammad Rahmani; Abdorreza Naser Moghadasi; Shayan Shahi; Sharareh Eskandarieh; Hossein Azizi; Alireza Hasanzadeh; Ali Ahmadzade; Ali Zare Dehnavi; Ramin Hamidi Farahani; Mohammad Aminianfar; Alireza Ranjbar Naeini
Journal:  Med Clin (Barc)       Date:  2022-08-10       Impact factor: 3.200

Review 4.  Potential triggers of MS.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Results Probl Cell Differ       Date:  2010

5.  Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection.

Authors:  Antonia Pignolo; Maria Aprile; Cesare Gagliardo; Giovanni Maurizio Giammanco; Marco D'Amelio; Paolo Aridon; Giuseppe La Tona; Giuseppe Salemi; Paolo Ragonese
Journal:  Neurol Int       Date:  2021-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.